Citius Oncology, Inc. CTOR Excess Stock Shares Outstanding
Excess Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ExcessStockSharesOutstanding.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s excess stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s excess stock shares outstanding?
- Citius Oncology, Inc. (CTOR) reported excess stock shares outstanding of 71.6M in Q1 2026.
- What does excess stock shares outstanding mean?
- The number of common shares issued and outstanding that exceed a specific threshold or baseline, often used in the context of equity incentive plans or capital structure adjustments. This metric helps investors understand potential dilution effects and the total equity base available for trading. It is essential for calculating accurate earnings per share and evaluating capital structure management.